Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.21.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Net revenue:    
Total revenues $ 914 $ 30
Operating expenses:    
Cost of sales 48 0
Selling, general and administrative 39,282 11,053
Research and development 9,833 13,835
Amortization of intangible assets 523 286
Other expense, net (1,771) (1,916)
Total cost and operating expenses 51,457 27,090
Loss from operations (50,543) (27,060)
Interest income 172 890
Net loss before income taxes (50,371) (26,170)
Income tax expense (benefit) 8 (238)
Net loss (50,379) (25,932)
Other comprehensive loss:    
Unrealized gain on available-for-sale securities, net of tax of $nil 6 0
Comprehensive loss $ (50,373) $ (25,932)
Net loss per common share (expressed in $ per share) $ (0.40) $ (0.23)
Weighted-average common shares outstanding used in computation of basic and diluted loss per share 127,401 112,209
Licensing revenue    
Net revenue:    
Total revenues $ 884 $ 0
Contract revenue    
Net revenue:    
Total revenues $ 30 $ 30